State-of-the-Art Cardiovascular Medicine in Asia 2021
Submission Deadline: 1 Jan 2022
Guest Editors
Faculty of Medicine, Macau University of Science and Technology, Taipa, Macau, China
Interests: the pathogenesis and treatment of hyperlipidaemia; hypertension; the metabolic syndrome and diabetes the clinical pharmacology; toxicology and pharmacogenetics of drugs; particularly in the cardiovascular field
Special Issues in IMR Press journals
Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
Interests: sleep apnea; sleep disorders; heart failure; hemodynamics; positive airway pressure; telemedicine
Special Issue in IMR Press journals
Special Issue in Perioperative Management in Cardiac Surgery
Special Issue Information
Dear Colleagues,
This Special Issue aims to provide a comprehensive overview of state-of-the-art of Cardiovascular Medicine in Asia. We invite research papers that will consolidate our understanding in this area. The Special Issue will publish full research articles and systematic reviews. Potential topics include, but are not limited to, the following research areas:
• cardiovascular imaging
• high blood pressure and cardiovascular disease
• cardiovascular tissue engineering
• meta‐analysis based on cardiovascular outcomes trials
• pathophysiology of chronic heart failure
• molecular genetics of cardiovascular disease: clinical implications
• cardiac arrhythmias
• biomarkers in Cardiovascular Medicine
It is my pleasure to invite you to submit manuscripts on the subject “State-of-the-Art Cardiovascular Medicine in Asia 2021” for this Special Issue. Full papers and communications, as well as comprehensive reviews, are welcome. Please feel free to contact me, the guest editor, in case of further questions.
Prof. Brian Tomlinson and Assoc. Prof. Takatoshi Kasai
Guest Editor
Keywords
- Cardiovascular anatomy
- Cardiac physiology
- Imaging techniques
- Cardiac regeneration
- Congenital heart disease
- Arrhythmias
- Animal models for cardiovascular diseases
- Genetics
- Blood pressure
- Biomarkers
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (47)
Rev. Cardiovasc. Med. 2022, 23(7), 235; https://doi.org/10.31083/j.rcm2307235
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(6), 190; https://doi.org/10.31083/j.rcm2306190
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(5), 175; https://doi.org/10.31083/j.rcm2305175
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(5), 162; https://doi.org/10.31083/j.rcm2305162
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(4), 121; https://doi.org/10.31083/j.rcm2304121
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(4), 115; https://doi.org/10.31083/j.rcm2304115
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(3), 99; https://doi.org/10.31083/j.rcm2303099
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(3), 94; https://doi.org/10.31083/j.rcm2303094
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(3), 84; https://doi.org/10.31083/j.rcm2303084
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(2), 65; https://doi.org/10.31083/j.rcm2302065
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(2), 64; https://doi.org/10.31083/j.rcm2302064
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(2), 60; https://doi.org/10.31083/j.rcm2302060
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(2), 59; https://doi.org/10.31083/j.rcm2302059
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(2), 52; https://doi.org/10.31083/j.rcm2302052
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(2), 45; https://doi.org/10.31083/j.rcm2302045
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(1), 30; https://doi.org/10.31083/j.rcm2301030
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(1), 26; https://doi.org/10.31083/j.rcm2301026
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(1), 18; https://doi.org/10.31083/j.rcm2301018
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(1), 8; https://doi.org/10.31083/j.rcm2301008
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2022, 23(1), 10; https://doi.org/10.31083/j.rcm2301010
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(4), 1721-1728; https://doi.org/10.31083/j.rcm2204180
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(4), 1693-1700; https://doi.org/10.31083/j.rcm2204177
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(4), 1535-1539; https://doi.org/10.31083/j.rcm2204157
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(4), 1523-1533; https://doi.org/10.31083/j.rcm2204156
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(4), 1451-1459; https://doi.org/10.31083/j.rcm2204149
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(4), 1361-1381; https://doi.org/10.31083/j.rcm2204142
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(4), 1295-1309; https://doi.org/10.31083/j.rcm2204136
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(4), 1185-1196; https://doi.org/10.31083/j.rcm2204127
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 967-973; https://doi.org/10.31083/j.rcm2203105
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 947-958; https://doi.org/10.31083/j.rcm2203103
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 931-938; https://doi.org/10.31083/j.rcm2203101
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 895-901; https://doi.org/10.31083/j.rcm2203096
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 873-881; https://doi.org/10.31083/j.rcm2203093
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 865-872; https://doi.org/10.31083/j.rcm2203092
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 807-816; https://doi.org/10.31083/j.rcm2203087
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 769-777; https://doi.org/10.31083/j.rcm2203083
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 613-624; https://doi.org/10.31083/j.rcm2203072
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 573-584; https://doi.org/10.31083/j.rcm2203069
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 1037-1045; https://doi.org/10.31083/j.rcm2203113
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 1029-1035; https://doi.org/10.31083/j.rcm2203112
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 1019-1027; https://doi.org/10.31083/j.rcm2203111
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 1009-1017; https://doi.org/10.31083/j.rcm2203110
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(3), 1003-1008; https://doi.org/10.31083/j.rcm2203109
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(2), 531-536; https://doi.org/10.31083/j.rcm2202061
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(2), 521-529; https://doi.org/10.31083/j.rcm2202060
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(2), 513-519; https://doi.org/10.31083/j.rcm2202059
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Rev. Cardiovasc. Med. 2021, 22(2), 505-512; https://doi.org/10.31083/j.rcm2202058
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)